Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Nature (28)
Leukemia (13)
British Journal of Cancer (7)
Scientific Reports (7)
Nature Communications (5)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (76)
Amendments and Corrections (5)
Reviews (3)
Comments & Opinion (2)
Correspondence (2)

Subject Check one or more subjects to show results from those subjects only.

Biochemistry
Biogeochemistry
Biophysics
Biotechnology
Cancer
Cell biology
Chemical biology
Climate sciences
Diseases
Drug discovery
Ecology
Genetics
Health care
Immunology
Medical research
Microbiology
Nephrology
Neurology
Neuroscience
Plant sciences

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 51–88 of 88 results

Advanced filters: Author: J Dengler Clear advanced filters

Blindness in patients with diabetes who have been screened for eye disease

M C Rhatigan
G P Leese
S T D Roxburgh
Research01 Mar 1999
Eye

Volume: 13, P: 166-169
Accumulation and marine forcing of ice dynamics in the western Ross Sea during the last deglaciation

Ice-shelf grounding lines off the coast of Antarctica have retreated over the past 20,000 years. Precise dating of moraines suggests the timing of retreat in the Ross Sea was controlled by the interplay between accumulation and ocean forcing.

Brenda L. Hall
George H. Denton
Tobias N. B. Koffman
Research13 Jul 2015
Nature Geoscience

Volume: 8, P: 625-628
Opioid Self-Administration is Attenuated by Early-Life Experience and Gene Therapy for Anti-Inflammatory IL-10 in the Nucleus Accumbens of Male Rats

Michael J Lacagnina
Ashley M Kopec
Staci D Bilbo
ResearchOpen Access24 Apr 2017
Neuropsychopharmacology

Volume: 42, P: 2128-2140
Prognosis and quality of life in patients with locally advanced rectal cancer after abdominoperineal resection in the CAO/ARO/AIO-04 randomized phase 3 trial

Jochen Gaedcke
Malte Sahrhage
H. Leber
ResearchOpen Access13 Feb 2025
Scientific Reports

Volume: 15, P: 1-12
Expression and function of angiopoietin-1 in breast cancer

A J Hayes
W-Q Huang
L-Y Li
ResearchOpen Access10 Oct 2000
British Journal of Cancer

Volume: 83, P: 1154-1160
Flunarizine, a Calcium Channel Antagonist, Is Partially Prophylactically Neuroprotective in Hypoxic-Ischemic Encephalopathy in the Fetal Sheep

Alistair J Gunn
Christopher E Williams
Peter D Gluckman
Research01 Jun 1994
Pediatric Research

Volume: 35, P: 657-663
Enhanced immune costimulatory activity of primary acute myeloid leukaemia blasts after retrovirus-mediated gene transfer of B7.1

WJR Hirst
A Buggins
GJ Mufti
Research01 Jul 1997
Gene Therapy

Volume: 4, P: 691-699
Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations

I Boland
G Vassal
A Gouyette
ResearchOpen Access29 Jan 1999
British Journal of Cancer

Volume: 79, P: 787-792
A quantitative analysis of the reduction in oxygen levels required to induce up-regulation of vascular endothelial growth factor (VEGF) mRNA in cervical cancer cell lines

J A Chiarotto
R P Hill
ResearchOpen Access25 Jun 1999
British Journal of Cancer

Volume: 80, P: 1518-1524
Spectrin-beta 2 facilitates the selective accumulation of GABA_A receptors at somatodendritic synapses

The subunit composition of GABA_A receptors and their interaction with beta spectrin complexes influences their localization between the neuronal axon initial segment or dendrites.

Joshua L. Smalley
Noell Cho
Stephen J. Moss
ResearchOpen Access05 Jan 2023
Communications Biology

Volume: 6, P: 1-13
The BCL-2 family member BOK promotes KRAS-driven lung cancer progression in a p53-dependent manner

Anna-Lena Meinhardt
Enkhtsetseg Munkhbaatar
Philipp J. Jost
ResearchOpen Access29 Jan 2022
Oncogene

Volume: 41, P: 1376-1382
Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)

B Hanfstein
M C Müller
A Hochhaus
Research26 Mar 2012
Leukemia

Volume: 26, P: 2096-2102
Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib

B Hanfstein
V Shlyakhto
M C Müller
Research06 May 2014
Leukemia

Volume: 28, P: 1988-1992
The upper cervical spinal cord in ALS assessed by cross-sectional and longitudinal 3T MRI

Thomas Wimmer
Frank Schreiber
Stefanie Schreiber
ResearchOpen Access04 Feb 2020
Scientific Reports

Volume: 10, P: 1-10
Novel pathway in Bcr-Abl signal transduction involves Akt-independent, PLC-γ1-driven activation of mTOR/p70S6-kinase pathway

B Markova
C Albers
T Fischer
Research02 Nov 2009
Oncogene

Volume: 29, P: 739-751
Potent efficacy of MCL-1 inhibitor-based therapies in preclinical models of mantle cell lymphoma

Michael A. Dengler
Charis E. Teh
Jerry M. Adams
Research26 Nov 2019
Oncogene

Volume: 39, P: 2009-2023
The basis of T-cell-mediated immunity to chronic myelogenous leukemia

Jeffrey J Molldrem
Shreya Kant
Sijie Lu
Reviews12 Dec 2002
Oncogene

Volume: 21, P: 8668-8673
Erratum: Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML

C Schütz
S Inselmann
A Burchert
Amendments and Corrections30 Jan 2018
Leukemia

Volume: 32, P: 1053
Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse

Michael J Lacagnina
Phillip D Rivera
Staci D Bilbo
Reviews11 Jul 2016
Neuropsychopharmacology

Volume: 42, P: 156-177
Combination of imatinib with rapamycin or RAD001 acts synergistically only in Bcr-Abl-positive cells with moderate resistance to imatinib

J Dengler
N von Bubnoff
J Duyster
Correspondence30 Jun 2005
Leukemia

Volume: 19, P: 1835-1838
Long-term outcome of high-dose melphalan and autologous stem cell transplantation for AL amyloidosis

J B Perz
A Rahemtulla
J F Apperley
Research27 Mar 2006
Bone Marrow Transplantation

Volume: 37, P: 937-943
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

R Hehlmann
M Lauseker
J Hasford
ResearchOpen Access14 Aug 2017
Leukemia

Volume: 31, P: 2398-2406
Rapid achievement of complete donor chimerism and low regimen-related toxicity after reduced conditioning with fludarabine, carmustine, melphalan and allogeneic transplantation

R Wäsch
S Reisser
J Finke
Research28 Jul 2000
Bone Marrow Transplantation

Volume: 26, P: 243-250
Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML

Rüdiger Hehlmann
Astghik Voskanyan
J. Mayer
Amendments and Corrections10 Sept 2020
Leukemia

Volume: 34, P: 2823
Correction: Corrigendum: 1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function

Mathias Gorski
Peter J. van der Most
Christian Fuchsberger
Amendments and CorrectionsOpen Access26 May 2017
Scientific Reports

Volume: 7, P: 1
Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV

L Kalmanti
S Saussele
R Hehlmann
Research13 Feb 2015
Leukemia

Volume: 29, P: 1123-1132
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML

C Schütz
S Inselmann
A Burchert
Research11 Jan 2017
Leukemia

Volume: 31, P: 829-836
Elevated PIN1 expression by C/EBPα-p30 blocks C/EBPα-induced granulocytic differentiation through c-Jun in AML

J A Pulikkan
V Dengler
G Behre
Research08 Apr 2010
Leukemia

Volume: 24, P: 914-923
Retinitis pigmentosa: rapid neurodegeneration is governed by slow cell death mechanisms

A Sahaboglu
O Paquet-Durand
F Paquet-Durand
ResearchOpen Access07 Feb 2013
Cell Death & Disease

Volume: 4, P: e488
Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR–ABL1-positive acute lymphoblastic leukemia

H Pfeifer
B Wassmann
O G Ottmann
Research05 Dec 2012
Leukemia

Volume: 27, P: 1254-1262
Characterization of a novel human BFL-1-specific monoclonal antibody

Lahiru Gangoda
Charis E. Teh
Marco J. Herold
Comments & Opinion12 Nov 2019
Cell Death & Differentiation

Volume: 27, P: 826-828
Non-coding RNAs and ferroptosis: potential implications for cancer therapy

Amar Balihodzic
Felix Prinz
Martin Pichler
ReviewsOpen Access14 Apr 2022
Cell Death & Differentiation

Volume: 29, P: 1094-1106
High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG

E Lengfelder
C Haferlach
T Büchner
Research10 Sept 2009
Leukemia

Volume: 23, P: 2248-2258
EGFR mutational status in a large series of Caucasian European NSCLC patients: data from daily practice

S Gahr
R Stoehr
W Dietmaier
ResearchOpen Access03 Sept 2013
British Journal of Cancer

Volume: 109, P: 1821-1828
Occurrence of donor-derived CLL 8 years after sibling donor SCT for CML

J B Perz
M Ritgen
P Dreger
Correspondence04 Aug 2008
Bone Marrow Transplantation

Volume: 42, P: 687-688
Direct improvement of quality of life using a tailored quality of life diagnosis and therapy pathway: randomised trial in 200 women with breast cancer

M Klinkhammer-Schalke
M Koller
W Lorenz
ResearchOpen Access07 Feb 2012
British Journal of Cancer

Volume: 106, P: 826-838
Implementing a system of quality-of-life diagnosis and therapy for breast cancer patients: results of an exploratory trial as a prerequisite for a subsequent RCT

M Klinkhammer-Schalke
M Koller
W Lorenz
ResearchOpen Access29 Jul 2008
British Journal of Cancer

Volume: 99, P: 415-422
Excessive HDAC activation is critical for neurodegeneration in the rd1 mouse

J Sancho-Pelluz
M V Alavi
P Ekström
ResearchOpen Access11 Feb 2010
Cell Death & Disease

Volume: 1, P: e24